A significant, gradual decrease in circulating DPP4 activity occurred concurrently with worsening disease severity among hospitalized COVID-19 patients (none of them on DPP4 inhibitor), and the lowest DPP4 values occurred in the group of those who subsequently died during their hospital stay. The gene discussed is DPP4; the disease is COVID-19.